Advertisement

Topics

Sangamo BioSciences Company Profile

01:38 EST 19th November 2017 | BioPortfolio

Sangamo BioSciences develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particular class of transcription factors known as zinc finger DNA-binding proteins, or ZFPs. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression, and consequently, cell function.

Sangamo is commercializing its technology for applications in pharmaceutical drug discovery, human therapeutics, plant agriculture, clinical diagnostics, and industrial biotechnology. Over 20 leading pharmaceutical and biotechnology companies have used Sangamo’s Universal GeneTools™ to accelerate their understanding and control of gene function and their validation of new drug targets. In addition, Sangamo is working with Edwards Lifesciences Corporation to develop ZFP-based therapeutics for cardiovascular disease. Sangamo is also exploring novel treatments for clinical indications in cancer and infectious diseases.

Location

Point Richmond Tech Center II
501 Canal Boulevard, Suite A100
Richmond
CA
94804
United States of America

Contact

Phone: 510-970-6000
Fax: 510-236-8951
Email: info@sangamo.com


News Articles [621 Associated News Articles listed on BioPortfolio]

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and In...

Sangamo Announces Plans For New Headquarters In Brisbane, California

In addition to laboratories, workstations and collaboration spaces, Sangamo will construct on-site in Brisbanea state-of-the-art, cGMP manufacturing facility to enable large-scale manufacturing of S...

Sangamo nets $68.2mm in FOPO

Sangamo Therapeutics Inc. (gene-based therapeutics) netted $68.2mm in a follow-on public offering of 10mm common shares at $7.25. The company intends to use the offering proceeds to fund continued R&...

Sangamo nets $78.4mm in FOPO

Sangamo Therapeutics Inc. (gene-based therapeutics) netted $78.4mm in a follow-on public offering of 11.5mm common shares (including full exercise of the 1.5mm over-allotment) at $7.25. The company i...

Sangamo Inks Deal for New HQ in Bay Area Biotech Hub

Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.

Sangamo begins SB-913 dosing in Phase I/II trial for MPS II

US-based Sangamo Therapeutics has commenced Phase I/II clinical trial CHAMPIONS for its investigational candidate SB-913 in patients with mucopolysaccharidosis type...Read More... The post Sangamo beg...

Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference

RICHMOND, Calif., Sept. 20, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will present a...

Pfizer, Sangamo advance early-stage gene therapy study for hemophilia A

Sangamo Therapeutics said that the first of the 20 participants has been dosed for its Phase I/II trial to test the tolerabil -More- 

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [67 Associated PubMed Articles listed on BioPortfolio]

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Amnesia and criminal responsibility.

Front cover.

Front cover.

Back cover.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [344 Associated Companies listed on BioPortfolio]

Sangamo BioSciences

Sangamo BioSciences develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particu...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development p...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Sangamo BioSciences" on BioPortfolio

We have published hundreds of Sangamo BioSciences news stories on BioPortfolio along with dozens of Sangamo BioSciences Clinical Trials and PubMed Articles about Sangamo BioSciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sangamo BioSciences Companies in our database. You can also find out about relevant Sangamo BioSciences Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record